PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins

Proceedings of the National Academy of Sciences of the United States of America
C BaillyM J Waring

Abstract

DNA molecules containing inosine in place of guanosine and/or 2,6-diaminopurine in place of adenine have been synthesized and tested as substrates for binding of sequence-selective ligands, both small and large. Footprinting patterns reveal that the binding sites for AT- or GC-specific antibiotics (distamycin or mithramycin, respectively) are completely changed in the modified DNAs, as expected for direct sequence readout involving contact with the purine 2-amino group. However, we also find large changes in the binding of HMG-D, a member of the HMG-1 family of chromosomal proteins, pointing to an indirect influence of the exocyclic amino group on ligand binding via an effect on the deformability of the double helix. This interpretation is confirmed by the finding that deoxyuridine-containing poly- and oligonucleotides, which lack the exocyclic methyl group of thymidine in the major groove, interact 5-10 times more strongly with HMG-D than do their counterparts containing natural nucleotides.

References

Mar 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·N C SeemanA Rich
May 1, 1992·Molecular and Cellular Biology·C R WagnerS C Elgin
Sep 29, 1992·Biochemistry·A StankusJ C Dabrowiak
Apr 1, 1990·Computer Applications in the Biosciences : CABIOS·J M Smith, D J Thomas
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M L KopkaR E Dickerson
Sep 1, 1987·European Journal of Biochemistry·J Portugal, M J Waring
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M CollA Rich
Dec 20, 1985·Journal of Molecular Biology·H R Drew, A A Travers
Feb 1, 1985·Journal of Biomolecular Structure & Dynamics·V B Zhurkin
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M W Van DykeP B Dervan
Jun 1, 1984·Cell·H R Drew, A A Travers
Oct 13, 1995·Journal of Molecular Biology·C BaillyA A Travers
Aug 1, 1995·Nature Structural Biology·A A Travers
Jan 1, 1995·Nature Structural Biology·R T Sauer
Dec 20, 1994·Biochemistry·C S ChowS J Lippard
Jul 6, 1993·Biochemistry·M Sastry, D J Patel
Jan 1, 1993·Environmental and Molecular Mutagenesis·A J Katz, T A Foley
Sep 11, 1993·Nucleic Acids Research·S S NerA A Travers
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·A FlausT J Richmond
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·F WielandW Schaefer

❮ Previous
Next ❯

Citations

Jan 1, 1997·Biopolymers·A Travers, H Drew
Oct 18, 1994·Biochimica Et Biophysica Acta·M KrupskyR H Goldstein
Feb 17, 1998·Trends in Neurosciences·D S AuldR Quirion
Jul 17, 1998·Current Opinion in Structural Biology·J B Chaires
Dec 5, 2000·Current Opinion in Chemical Biology·E T Kool
Jun 26, 2001·European Journal of Biochemistry·F A TaniousC Bailly
Jan 29, 2002·Nucleic Acids Research·B WellenzohnK R Liedl
Jun 29, 1999·Cold Spring Harbor Symposia on Quantitative Biology·A KumarE P Geiduschek
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M ButtinelliA Travers
Apr 7, 2012·Archives of Microbiology·Sukhendu Mandal, Sujoy K Das Gupta
Sep 15, 2004·Journal of Structural Biology·Johanna VirstedtAndrew A Travers
Apr 1, 1997·Current Biology : CB·A Travers
Aug 9, 2001·Journal of Molecular Biology·A Grove, L Lim
May 16, 1997·The Journal of Biological Chemistry·A GroveE P Geiduschek
Jun 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mélanie LambertMarie-Hélène David-Cordonnier
Nov 18, 2020·Biopolymers·Andrew Travers
Apr 28, 2006·Journal of Cell Science·Marcela K SjöbergEliette Bonnefoy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.